Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Nat Rev Genet. 2010 May;11(5):345-55. doi: 10.1038/nrg2776. Epub 2010 Apr 8.
Over the past decade, it has been shown that alternative splicing (AS) is a major mechanism for the enhancement of transcriptome and proteome diversity, particularly in mammals. Splicing can be found in species from bacteria to humans, but its prevalence and characteristics vary considerably. Evolutionary studies are helping to address questions that are fundamental to understanding this important process: how and when did AS evolve? Which AS events are functional? What are the evolutionary forces that shaped, and continue to shape, AS? And what determines whether an exon is spliced in a constitutive or alternative manner? In this Review, we summarize the current knowledge of AS and evolution and provide insights into some of these unresolved questions.
在过去的十年中,已经表明选择性剪接 (AS) 是增强转录组和蛋白质组多样性的主要机制,尤其是在哺乳动物中。剪接可以在从细菌到人类的物种中发现,但它的普遍性和特征差异很大。进化研究有助于解决理解这一重要过程的基本问题:AS 是如何以及何时进化的?哪些 AS 事件是有功能的?是什么进化力量塑造了并继续塑造着 AS?以及是什么决定了外显子是以组成性还是选择性方式剪接的?在这篇综述中,我们总结了 AS 和进化的现有知识,并深入探讨了其中一些尚未解决的问题。